These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 24599015

  • 1. A novel three-step approach for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.
    Hirashima C, Ohkuchi A, Takahashi K, Suzuki H, Matsubara S, Suzuki M.
    Hypertens Res; 2014 Jun; 37(6):519-25. PubMed ID: 24599015
    [Abstract] [Full Text] [Related]

  • 2. Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.
    Ohkuchi A, Hirashima C, Takahashi K, Suzuki H, Matsubara S, Suzuki M.
    Hypertens Res; 2013 Dec; 36(12):1073-80. PubMed ID: 23966056
    [Abstract] [Full Text] [Related]

  • 3. Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia.
    Ohkuchi A, Hirashima C, Matsubara S, Takahashi K, Matsuda Y, Suzuki M.
    Hypertension; 2011 Nov; 58(5):859-66. PubMed ID: 21947468
    [Abstract] [Full Text] [Related]

  • 4. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J, Shen J, Jiang Y, Zhou X, Qi H, Liu X, Liu J, Yang J, Bian X.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A, Maiz N, Garcia-Mandujano R, Penco JM, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [Abstract] [Full Text] [Related]

  • 6. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
    Kienast C, Moya W, Rodriguez O, Jijón A, Geipel A.
    J Matern Fetal Neonatal Med; 2016 Nov; 29(4):537-43. PubMed ID: 25708492
    [Abstract] [Full Text] [Related]

  • 8. Plasma level of hydroxysteroid (17-β) dehydrogenase 1 in the second trimester is an independent risk factor for predicting preeclampsia after adjusting for the effects of mean blood pressure, bilateral notching and plasma level of soluble fms-like tyrosine kinase 1/placental growth factor ratio.
    Ohkuchi A, Ishibashi O, Hirashima C, Takahashi K, Matsubara S, Takizawa T, Suzuki M.
    Hypertens Res; 2012 Dec; 35(12):1152-8. PubMed ID: 22786566
    [Abstract] [Full Text] [Related]

  • 9. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
    Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Maynard SE.
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
    [Abstract] [Full Text] [Related]

  • 10. Development of pre-eclampsia within 4 weeks of sFlt-1/PlGF ratio > 38: comparison of performance at 31-34 vs 35-37 weeks' gestation.
    Dragan I, Wright D, Fiolna M, Leipold G, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2017 Feb; 49(2):209-212. PubMed ID: 27671743
    [Abstract] [Full Text] [Related]

  • 11. Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation.
    Lai J, Garcia-Tizon Larroca S, Peeva G, Poon LC, Wright D, Nicolaides KH.
    Fetal Diagn Ther; 2014 Feb; 35(4):240-8. PubMed ID: 24853452
    [Abstract] [Full Text] [Related]

  • 12. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
    De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D'anna R.
    Acta Obstet Gynecol Scand; 2008 Feb; 87(8):837-42. PubMed ID: 18607829
    [Abstract] [Full Text] [Related]

  • 13. Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor.
    Rohra DK, Zeb A, Qureishi RN, Azam SI, Khan NB, Zuberi HS, Sikandar R.
    Natl Med J India; 2012 Feb; 25(2):68-73. PubMed ID: 22686711
    [Abstract] [Full Text] [Related]

  • 14. Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia.
    van Helden J, Weiskirchen R.
    Clin Biochem; 2015 Nov; 48(16-17):1113-9. PubMed ID: 26129879
    [Abstract] [Full Text] [Related]

  • 15. Maternal serum soluble fms-like tyrosine kinase-1 at 22 and 32 weeks in the prediction of pre-eclampsia.
    Wright D, Krajewska K, Bogdanova A, Wright A, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):755-61. PubMed ID: 26726123
    [Abstract] [Full Text] [Related]

  • 16. Prediction of imminent preeclampsia at 35-37 weeks gestation.
    Ciobanu A, Wright A, Panaitescu A, Syngelaki A, Wright D, Nicolaides KH.
    Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
    [Abstract] [Full Text] [Related]

  • 17. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation.
    Tsiakkas A, Saiid Y, Wright A, Wright D, Nicolaides KH.
    Am J Obstet Gynecol; 2016 Jul; 215(1):87.e1-87.e17. PubMed ID: 26875953
    [Abstract] [Full Text] [Related]

  • 18. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM, Wright D, Casanova C, Campanero M, Nicolaides KH.
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [Abstract] [Full Text] [Related]

  • 19. Increased serum levels of sFlt-1/PlGF ratio in preeclamptic women with onset at <32 weeks compared with ≥32 weeks.
    Suzuki H, Hirashima C, Nagayama S, Takahashi K, Yamamoto T, Matsubara S, Ohkuchi A.
    Pregnancy Hypertens; 2018 Apr; 12():96-103. PubMed ID: 29674208
    [Abstract] [Full Text] [Related]

  • 20. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
    Andersen LB, Dechend R, Jørgensen JS, Luef BM, Nielsen J, Barington T, Christesen HT.
    Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.